BECTON, DICKINSON AND COMPANY Cash and Cash Equivalents, Fair Value Disclosure
BECTON, DICKINSON AND COMPANY (BDX) had Cash and Cash Equivalents, Fair Value Disclosure of $18.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, Fair Value Disclosure $18.00M.
- 2026-03-31: Cash and Cash Equivalents, Fair Value Disclosure $5.00M.
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure $0.00.
- 2025-09-30: Cash and Cash Equivalents, Fair Value Disclosure $18.00M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure | Cash and Cash Equivalents, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $18.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $5.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-09 | |
| 2025-09-30 | $18.00M 10-Q · filed 2026-08-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $285.00M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $1.56B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $411.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $311.00M 10-Q · filed 2024-02-01 | |
| 2023-09-30 | $373.00M 10-K · filed 2024-11-27 | |
| 2023-06-30 | $100.00M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $50.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $1.00M 10-K · filed 2023-11-21 | |
| 2022-06-30 | $650.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $609.00M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $100.00M 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $200.00M 10-K · filed 2022-11-22 | |
| 2021-06-30 | $800.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $825.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.10B 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $1.55B 10-K · filed 2021-11-24 | |
| 2020-06-30 | $1.72B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.80B 10-Q · filed 2020-05-07 | |
| 2019-09-30 | $39.00M 10-K · filed 2020-11-25 | |
| 2019-03-31 | $25.00M 10-Q · filed 2019-05-09 | |
| 2018-09-30 | $228.00M 10-K · filed 2019-11-27 | |
| 2018-06-30 | $258.00M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $12.00M 10-Q · filed 2018-05-03 | |
| 2017-09-30 | $2.03B 10-K · filed 2018-11-21 | |
| 2015-06-30 | $217.00M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.18B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $6.81B 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $1.04B 10-Q · filed 2015-08-06 | |
| 2014-06-30 | $985.00M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $1.02B 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $886.00M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $881.00M 10-Q · filed 2014-08-04 | |
| 2013-06-30 | $1.13B 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $1.17B 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.22B 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $1.07B 10-K · filed 2013-11-27 | $1.07B 10-K · filed 2012-11-21 |
| 2011-09-30 | $590.51M 10-K · filed 2012-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |